Addgene: ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.

This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Browse
Elizabeth White
Nouel et al

ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.
Nouel J, White EA
mBio. 2022 Nov 8:e0203322. doi: 10.1128/mbio.02033-22. PubMed Article

Plasmids from Article

ID	Plasmid	Purpose
191540	MSCV-neo C-HAonly ZER1	Protein expression of ZER1
191541	MSCV-neo C-HAonly HPV16 E7 E80A/D81A	Protein expression of HPV16 E7 E80A/D81A
191542	MSCV-P C-FlagHA HPV16-18 E7 Chimera A	Protein expression of HPV16 E7 Chimera A
191543	MSCV-P C-FlagHA HPV16-18 E7 Chimera B	Protein expression of HPV16 E7 Chimera B
191544	MSCV-P C-FlagHA HPV16-18 E7 Chimera C	Protein expression of HPV16 E7 Chimera C
191545	MSCV-P C-FlagHA HPV16 E7 Mutant 1	Protein expression of HPV16 E7 Mutant 1
191546	MSCV-P C-FlagHA HPV16 E7 Mutant 2	Protein expression of HPV16 E7 Mutant 2
191547	MSCV-P C-FlagHA HPV16 E7 H73A	Protein expression of HPV16 E7 H73A
191548	MSCV-P C-FlagHA HPV16 E7 E80A/D81A	Protein expression of HPV16 E7 E80A/D81A
191549	LentiCRISPR v2 sgZER1-1	Expression of spCas9 and sgRNA targetting ZER1
191550	LentiCRISPR v2 sgZER1-2	Expression of spCas9 and sgRNA targetting ZER1

Antibodies from Article